Portfolio company
HiberGene
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
HiberGene Diagnostics manufactures molecular diagnostic tests for infectious diseases for sale to healthcare providers and institutions via a global network of independent distributors.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Abacus Diagnostica
This company develops molecular diagnostic systems for infectious disease testing, serving hospital laboratories and healthcare units.
Limosa Immunodiagnostics
This company develops diagnostic tests for latent tuberculosis and other immune-related diseases for patients and healthcare providers.
D-Nome
This company develops point-of-care molecular diagnostic kits and genomic sequencing tools for healthcare providers, laboratories, and agricultural clients to detect infectious diseases.
AgenDx Biosciences
This company develops a molecular diagnostics platform to provide cost-effective cancer and infectious disease testing for clinical settings and healthcare providers.
Oxford Immunotec
This diagnostics company develops proprietary assays for immunology and infectious diseases, primarily providing tuberculosis testing kits to healthcare providers and laboratories.
NeuMoDx Molecular
The company develops automated molecular diagnostic systems and reagents for nucleic acid testing in clinical and hospital laboratories.
GNA Biosolutions GmbH
GNA Biosolutions GmbH manufactures ultrafast molecular diagnostic instruments and assays for healthcare providers to detect pathogens near patients or at the point of care.
Sherlock Biosciences
This company develops molecular diagnostic tests using CRISPR and synthetic biology for healthcare providers and consumers to detect infectious diseases and other health conditions.
